S. 3411 · 115th Congress
Affordable Medications Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
SmithSponsor14 cosponsors · 13 D, 1 I
D
Brown
TB
D
Baldwin
RB
D
Blumenthal
CB
D
Booker
RD
D
Durbin
KG
D
Gillibrand
MH
D
Hassan
AK
D
Klobuchar
JM
D
Merkley
JR
D
Reed
BS
I
Sanders
TU
D
Udall
SW
D
Whitehouse
EW
D
Warren14 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill alters various provisions relating to prescription-drug pricing and affordability, including drug manufacturer reporting requirements, Medicare price negotiation, and drug exclusivity periods.
What it does: CRS summary · Introduced in Senate · Sep 5, 2018
Affordable Medications Act
This bill alters various provisions relating to prescription-drug pricing and affordability, including drug manufacturer reporting requirements, Medicare price negotiation, and drug exclusivity periods.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Affordable Medications Act
Latest action (Sep 5, 2018): Read twice and referred to the Committee on Finance.
Policy area: Health · Origin: Senate · Introduced: Sep 5, 2018
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.